Dentsply Sirona (XRAY)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$11.38-0.44%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · XRAY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 3,643.0 | 3,680.0 | 3,793.0 | 3,965.0 | 3,922.0 | 4,231.0 | 3,339.0 | 4,022.0 | 3,986.3 | 3,993.4 | 0.0 | 0.0 | 2,922.6 | 2,950.8 | 2,928.4 | 2,537.7 | 2,221.0 | 2,159.4 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 3,993.4 | 0.0 | 0.0 | 2,922.6 | 2,950.8 | 2,928.4 | 2,537.7 | 2,221.0 | 2,159.4 |
| Cost of Revenues | 1,839.0 | 1,840.0 | 1,835.0 | 1,879.0 | 1,795.0 | 1,884.0 | 1,683.0 | 1,858.0 | 1,918.0 | — | — | — | — | — | — | — | — | — |
| Gross Profit | 1,804.0 | 1,840.0 | 1,958.0 | 2,086.0 | 2,127.0 | 2,347.0 | 1,656.0 | 2,164.0 | 2,068.0 | 2,188.5 | — | — | 1,599.8 | 1,577.4 | 1,556.4 | 1,273.4 | 1,130.2 | 1,106.4 |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 1,453.0 | 1,438.0 | 1,605.0 | 1,613.0 | 1,589.0 | 1,551.0 | 1,302.0 | 1,587.0 | 1,719.0 | 1,674.7 | 1,523.0 | 1,077.3 | 1,143.1 | 1,144.8 | 1,148.7 | 936.8 | 738.9 | — |
| R&D Expenses | 166.0 | 150.0 | 165.0 | 184.0 | 174.0 | 171.0 | 123.0 | 143.0 | 161.0 | 151.7 | 128.5 | 74.9 | 80.8 | 85.1 | 85.4 | 85.4 | 66.7 | — |
| Operating Income | (310.0) | (422.0) | (879.0) | (85.0) | (937.0) | 608.0 | (3.0) | 353.0 | (958.0) | (1,562.3) | 454.7 | 375.2 | 445.6 | 419.2 | 381.9 | 300.7 | 380.3 | 381.2 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 88.0 | 69.0 | 81.0 | 65.0 | 61.0 | 48.0 | 30.0 | 37.0 | 38.3 | 35.9 | 55.9 | 46.9 | 49.6 | 56.9 | 43.8 | 25.1 | 21.9 |
| Interest & Investment Income | — | — | — | — | — | — | 1.0 | 2.0 | 2.0 | 2.4 | 2.0 | 2.2 | 5.6 | 8.1 | 8.8 | 8.2 | 4.3 | 5.0 |
| Net Interest Expenses | — | — | — | — | — | — | 47.0 | 28.0 | 35.0 | 35.9 | 33.9 | 53.7 | 41.3 | 41.5 | 48.1 | 35.6 | 20.8 | 16.9 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.6 | — | — | — |
| Asset Writedown | — | — | — | — | — | — | — | 47.2 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (347.0) | (486.0) | (936.0) | (175.0) | (1,055.0) | 545.0 | (60.0) | 345.0 | (958.0) | (1,603.5) | 440.9 | 329.7 | 404.4 | 369.3 | 330.7 | 256.1 | 357.7 | 363.4 |
| Income Tax Expense | 200.0 | 112.0 | (26.0) | (43.0) | (105.0) | 134.0 | 23.0 | 82.0 | 53.0 | (53.2) | 9.5 | 77.0 | 81.1 | 52.2 | 8.9 | 11.0 | 89.2 | 88.9 |
| Net Income | ||||||||||||||||||
| Minority Interest | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.3) | 1.5 | (0.1) | 0.0 | 5.0 | 4.3 | 2.9 | 1.6 | 0.2 |
| Net Income | (546.0) | (598.0) | (910.0) | (132.0) | (950.0) | 411.0 | (73.0) | 256.0 | (1,011.0) | (1,550.0) | 429.9 | 251.2 | 322.9 | 313.2 | 314.2 | 244.5 | 265.7 | 274.3 |
| Per Share | ||||||||||||||||||
| Basic EPS | (2.73) | (3.00) | (4.48) | (0.62) | (4.41) | 1.88 | (0.33) | 1.15 | (4.51) | (6.76) | 1.97 | 1.79 | 2.28 | 2.20 | 2.22 | 1.73 | 1.85 | 1.85 |
| Diluted EPS | (2.72) | (3.00) | (4.48) | (0.62) | (4.41) | 1.87 | (0.33) | 1.14 | (4.51) | (6.76) | 1.94 | 1.76 | 2.24 | 2.16 | 2.18 | 1.70 | 1.82 | 1.83 |
| Revenue per Share | 18.17 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.64 | 0.64 | 0.56 | 0.50 | 0.43 | 0.40 | 0.38 | 0.35 | 0.35 | 0.31 | 0.29 | 0.27 | — | — | — | 0.20 | 0.20 |
| Basic Weighted Avg Shares | 199.7 | 199.4 | 203.2 | 212.0 | 215.5 | 218.4 | 219.2 | 223.1 | 224.3 | 229.4 | 218.0 | 140.0 | 141.7 | 142.7 | 141.9 | 141.4 | 144.0 | 148.3 |
| Diluted Weighted Avg Shares | 200.5 | 199.4 | 203.2 | 212.0 | 215.5 | 220.2 | 219.2 | 224.4 | 224.3 | 229.4 | 221.6 | 142.5 | 144.2 | 145.0 | 143.9 | 143.6 | 146.0 | 150.1 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | (70.0) | (530.0) | 258.0 | (609.0) | 955.0 | 331.0 | 676.0 | (627.0) | (1,245.9) | 726.4 | 498.1 | 574.7 | 547.1 | 511.1 | 385.8 | 446.2 | — |
| EBIT | (310.0) | (422.0) | (879.0) | (85.0) | (937.0) | 608.0 | (3.0) | 353.0 | (958.0) | (1,562.3) | 454.7 | 375.2 | 445.6 | 419.2 | 381.9 | 300.7 | 380.3 | 381.2 |
| Effective Tax Rate | -57.6% | — | — | 24.6% | 10.0% | 24.6% | -38.3% | 23.8% | -5.5% | 3.3% | 2.2% | 23.4% | 20.1% | 14.1% | 2.7% | 4.3% | 24.9% | 24.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.